Dr. Reddy's Labs Files 6-K, Confirms 20-F Reporting
Ticker: RDY · Form: 6-K · Filed: Dec 12, 2025 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, 6-K, reporting
Related Tickers: RDY
TL;DR
RDY filed a 6-K, confirming 20-F reporting. Standard procedure.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on December 12, 2025, reporting as a foreign private issuer. The filing confirms that the company files annual reports under Form 20-F. The company's principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana, India.
Why It Matters
This filing is a routine disclosure for foreign private issuers, confirming their reporting structure with the SEC and providing updated contact information.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain material financial or operational news.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Filer
- 8-2-337, Road No. 3, Banjara Hills Hyderabad, Telangana, India (location) — Principal executive office address
FAQ
What type of report is Dr. Reddy's Laboratories Ltd. submitting?
Dr. Reddy's Laboratories Ltd. is submitting a Form 6-K, which is a Report of Foreign Private Issuer.
When was this Form 6-K filed?
The Form 6-K was filed on December 12, 2025.
Does Dr. Reddy's Laboratories Ltd. file annual reports under Form 20-F or Form 40-F?
Dr. Reddy's Laboratories Ltd. files annual reports under cover of Form 20-F.
Where is the principal executive office of Dr. Reddy's Laboratories Ltd. located?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana, India.
What is the Commission File Number for Dr. Reddy's Laboratories Ltd.?
The Commission File Number is 1-15182.
Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.4 · Accepted 2025-12-12 06:10:04
Filing Documents
- rdy0830_6k.htm (6-K) — 36KB
- rdy0830_ex99-1.htm (EX-99.1) — 37KB
- rdy0830_ex99-1img01.jpg (GRAPHIC) — 4KB
- rdy0830_ex99-1img02.jpg (GRAPHIC) — 5KB
- rdy0830_ex99-1img03.jpg (GRAPHIC) — 10KB
- 0001575872-25-000757.txt ( ) — 100KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: December 12, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3